Comments on: UK supermarket to start selling cancer drugs http://lancastria.net/blog/uk-supermarket-to-start-selling-cancer-drugs.html Neuschwanstein, a castle that belongs in Blackburn Lancashire less the 4000 holes Fri, 18 May 2012 05:09:50 +0000 hourly 1 http://wordpress.org/?v=3.3.2 By: Neuschwanstein http://lancastria.net/blog/uk-supermarket-to-start-selling-cancer-drugs.html#comment-901 Neuschwanstein Sun, 10 Oct 2010 22:47:51 +0000 http://lancastria.net/blog/?p=2841#comment-901 German drugmaker Boehringer Ingelheim has stopped developing a drug dubbed the "pink Viagra" after failing to convince U.S. regulators the experimental pill could boost women's sex drive. "The decision was not made lightly, considering the advanced stage of development," chief executive Andreas Barner said on Friday of the hoped-for moneyspinner aimed at premenopausal women with a persistent and unexplained lack of sex drive. Boehringer's move marked the failure of the latest attempt to find a female counterpart to Pfizer's Viagra, the blockbuster blue pill for men. Drugmakers have tested various ways to boost female libido, but women's sex lives have proved difficult to target with medication. U.S. government advisers said in June that Boehringer's pink pill, based on the active ingredient flibanserin, offered little help to women and had unacceptable risks -- nearly 15 percent of women stopped taking a pill before a study ended due to side effects including depression, fainting and fatigue. That led the U.S. Food and Drug Administration to ask unlisted Boehringer in August for more information on flibanserin, which would have been marketed as Girosa. "The response of the authorities and the complexity and extent of further questions that would need to be addressed to potentially obtain registration for flibanserin have impacted the company's decision to focus on other pipeline projects," Boehringer said. Drugmakers have been searching for a medicine to improve women's sex lives since Viagra's debut 12 years ago. The market for a "pink Viagra" could stretch into the billions of dollars. http://www.reuters.com/article/idUSTRE6970TN20101008 German drugmaker Boehringer Ingelheim has stopped developing a drug dubbed the “pink Viagra” after failing to convince U.S. regulators the experimental pill could boost women’s sex drive.

“The decision was not made lightly, considering the advanced stage of development,” chief executive Andreas Barner said on Friday of the hoped-for moneyspinner aimed at premenopausal women with a persistent and unexplained lack of sex drive.

Boehringer’s move marked the failure of the latest attempt to find a female counterpart to Pfizer’s Viagra, the blockbuster blue pill for men. Drugmakers have tested various ways to boost female libido, but women’s sex lives have proved difficult to target with medication.

U.S. government advisers said in June that Boehringer’s pink pill, based on the active ingredient flibanserin, offered little help to women and had unacceptable risks — nearly 15 percent of women stopped taking a pill before a study ended due to side effects including depression, fainting and fatigue.

That led the U.S. Food and Drug Administration to ask unlisted Boehringer in August for more information on flibanserin, which would have been marketed as Girosa.

“The response of the authorities and the complexity and extent of further questions that would need to be addressed to potentially obtain registration for flibanserin have impacted the company’s decision to focus on other pipeline projects,” Boehringer said.

Drugmakers have been searching for a medicine to improve women’s sex lives since Viagra’s debut 12 years ago. The market for a “pink Viagra” could stretch into the billions of dollars.

http://www.reuters.com/article/idUSTRE6970TN20101008

]]> By: Neuschwanstein http://lancastria.net/blog/uk-supermarket-to-start-selling-cancer-drugs.html#comment-853 Neuschwanstein Tue, 05 Oct 2010 00:29:00 +0000 http://lancastria.net/blog/?p=2841#comment-853 A single dose of Viagra is being used to treat severe period pain. Around half of women suffer from cramps related to their menstrual cycle, and in up to 15 per cent of cases this affects their daily life. Primary dysmenorrhea, as it is known, occurs when an egg is released at the beginning of the cycle; at the same time blood supply to the muscles in the womb lining is reduced, causing them to contract painfully. This pain can be continuous, or may come and go; it can also extend from the lower abdomen to the legs. Symptoms are usually at their worst 24 hours after the cycle begins and stop after two days. It's thought that primary dysmenorrhea is triggered by excess production of hormone- like compounds which restrict blood supply to the uterine muscle, in turn causing pelvic pain. In a clinical trial at Penn State University in the U.S., women are being given a single dose of sildenafil citrate or Viagra. The theory is that the drug improves blood flow and as a result will lower pain levels. It has not been used before in the treatment of primary dysmenorrhea. A single dose of Viagra is being used to treat severe period pain. Around half of women suffer from cramps related to their menstrual cycle, and in up to 15 per cent of cases this affects their daily life. Primary dysmenorrhea, as it is known, occurs when an egg is released at the beginning of the cycle; at the same time blood supply to the muscles in the womb lining is reduced, causing them to contract painfully. This pain can be continuous, or may come and go; it can also extend from the lower abdomen to the legs. Symptoms are usually at their worst 24 hours after the cycle begins and stop after two days. It’s thought that primary dysmenorrhea is triggered by excess production of hormone- like compounds which restrict blood supply to the uterine muscle, in turn causing pelvic pain. In a clinical trial at Penn State University in the U.S., women are being given a single dose of sildenafil citrate or Viagra. The theory is that the drug improves blood flow and as a result will lower pain levels. It has not been used before in the treatment of primary dysmenorrhea.

]]>